Skip to Content

The Medical Letter on Drugs and Therapeutics
Objective, peer-reviewed evaluations of new FDA-approved drugs, and new information on previously approved drugs.
May 13, 2013 (Issue 1416)
  • Ospemifene (Osphena) for Dyspareunia
  • Alogliptin (Nesina) for Type 2 Diabetes
  • Omalizumab (Xolair) for Chronic Urticaria
Treatment Guidelines from The Medical Letter
Unbiased reviews of drug classes used to treat common disorders. Includes the doses, adverse effects and the recommendations of expert reviewers.
May 2013 (Issue 129)
  • The use of drugs to prevent and control symptoms of allergic disorders can be optimized when patients avoid exposure to specific allergens and/or environmental conditions that trigger or worsen their symptoms. [more]
  • Drugs for Bacterial Infections
  • Drugs for Psychiatric Disorders